High Court drugs ruling marks latest skirmish in war of words
The High Court ruling upholding the National Institute for Health and Clinical Excellence's decision over medication for Alzheimer's is just the latest skirmish in what promises to be protracted manoeuvring over drug use and pricing.
Register now for free to view this page
Please register now to access this content








